Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.34 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.34 |
| ▸ | SSTR4 | P31391 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6548551 | 1.00 | CES2 (0.36) | CES2CES1EPHX1PDK1PDK2 | |
| SCHEMBL3146924 | 0.97 | — | — | |
| SCHEMBL31344344 | 0.83 | — | — | |
| SCHEMBL28583545 | 0.81 | EPHX1 (0.35) | CES2CES1EPHX1PDK1PDK2 | |
| SCHEMBL879449 | 0.81 | LMNA (0.38) | CES2CES1EPHX1PDK1PDK2 | |
| SCHEMBL18621008 | 0.81 | LMNA (0.38) | CES2CES1EPHX1PDK1PDK2 | |
| SCHEMBL9897847 | 0.81 | LMNA (0.38) | CES2CES1EPHX1PDK1PDK2 | |
| SCHEMBL15151738 | 0.81 | EPHX1 (0.35) | CES2CES1EPHX1PDK1PDK2 | |
| SCHEMBL8502985 | 0.81 | LMNA (0.38) | CES2CES1EPHX1PDK1PDK2 | |
| SCHEMBL18513504 | 0.81 | LMNA (0.38) | CES2CES1EPHX1PDK1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119710701-A | Chlorine ion resistant medium roughening microetching liquid medicine | 南通群安电子材料有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-121974810-A | Method for preparing dihydroxyethyl cyclohexylamine by autocatalysis | 上海邦高化学有限公司 | 2026-05-05 | — | — | CN | disclosed |
| CN-119019877-B | Inorganic fireproof paint for building and preparation method thereof | 广州市福田化学工业涂料有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-119019877-B | Inorganic fireproof paint for building and preparation method thereof | 广州市福田化学工业涂料有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-119019877-A | Inorganic fireproof paint for building and preparation method thereof | 广州市福田化学工业涂料有限公司 | 2024-11-26 | — | — | CN | disclosed |
| US-20230303599-A1 | PRODRUGS OF PHOSPHONAMIDE NUCLEOTIDE ANALOGUES AND THEIR PHARMACEUTICAL USE | GILEAD SCIENCES, INC. | 2023-09-28 | — | — | US | disclosed |
| EP-3858844-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2021-08-04 | — | — | EP | disclosed |
| EP-3305796-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2021-03-31 | — | — | EP | disclosed |
| EP-3261146-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2020-09-23 | — | — | EP | disclosed |
| US-20100081693-A1 | THIADIAZOLE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-01 | — | — | US | disclosed |
| EP-1279686-B1 | Polymers from triazine derivatives | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2008-08-20 | — | — | EP | disclosed |
| WO-2008032858-A2 | THIADIAZOLE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-20 | — | — | WO | disclosed |
| US-6818726-B2 | FOR INTERMEDIATES AND MOLDED MATERIALS WITH IMPROVED TOUGHNESS AND HIGH FLAME RESISTANCE AND STRENGTH | AGROLINZ MELAMIN GMBH (AT) | 2004-11-16 | — | — | US | disclosed |
| US-20030045667-A1 | Polymers made from triazine derivatives | AGROLINZ MELAMIN GMBH (AT) | 2003-03-06 | — | — | US | disclosed |
| EP-1279686-A2 | Polymers from triazine derivatives | Agrolinz Melamin GmbH (AT) | 2003-01-29 | — | — | EP | disclosed |
| EP-1200494-A1 | COMPOUND | Rolic AG (CH) | 2002-05-02 | — | — | EP | disclosed |
| WO-2001007495-A1 | COMPOUND | ROLIC AG (CH) | 2001-02-01 | — | — | WO | disclosed |
| CN-1175211-A | 4, 4 -(disubstituted) cyclohexan-one monomers and related compounds | SMITHKLINE BEECHAM CORP (US) | 1998-03-04 | — | — | CN | disclosed |
| US-4184990-A | Process for the preparation of stable dispersions of polyisocyanate-polyaddition products in a hydroxyl containing compound as dispersing agent | BAYER AKTIENGESELLSCHAFT (DE) | 1980-01-22 | — | — | US | disclosed |
| US-4092275-A | Polyurethane resins prepared from active hydrogen containing material which is a dispersion of polyisocyanate-polyaddition products in hydroxyl containing compounds as dispersing agents | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303599-A1 | PRODRUGS OF PHOSPHONAMIDE NUCLEOTIDE ANALOGUES AND THEIR PHARMACEUTICAL USE | PNP, TYMP, NME2 | CES2 928/4885CES1 657/4885EPHX1 1282/4885 |
| US-20100081693-A1 | THIADIAZOLE COMPOUND AND USE THEREOF | NR2C2, NR4A3, NR0B2 | CES2 3850/4885CES1 3588/4885EPHX1 2854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.